AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Treatment

ICYMI – NIH’s Dr. Anthony Fauci Pens Op-Ed on Tools to End HIV/AIDS

Fauci

In case you missed it, last week Dr. Anthony Fauci shared an op-ed in The Washington Post: “No more excuses. We have the tools to end the HIV/AIDS pandemic.” Dr. Fauci, Director of the National Institute of Allergy and Infectious Diseases at NIH, observes, “[W]hy does this global pandemic continue to rage? It is not…

U.S. PEPFAR Teams-up with Digital Influencers in Campaign to Support Treatment Expansion to Stop HIV/AIDS

TreatmentForAll - UN Blog

“Treatment For All” campaign aims to use the power of social media for global change. On November 30, 2015, the eve of World AIDS Day, Emmy Award-winning television host Ricki Lake, digital influencers Wesley Stromberg, Sammy Wilkinson, Megan Nicole and Melvin Gregg, the United States Government President’s Emergency Plan for AIDS Relief (PEPFAR), Facebook and…

Remembering the Lessons of HIV/AIDS

Ronald Valdiserri

As some readers of this blog may already know, at the end of next month I will retire from the federal government after 27 years of service. I don’t plan to leave the field of public health; I’m just changing it up with a move to join the faculty of Johns Hopkins Bloomberg School of…

FDA Issues Final Industry Guidance for Developing Antiretroviral Drugs for HIV Treatment

FDA

This week, FDA announced the availability of a final guidance [PDF 610 KB] for industry entitled “Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment.” The guidance provides recommendations for the development of antiretroviral drugs regulated within the FDA Center for Drug Evaluation and Research for the treatment of HIV infection. This guidance assists sponsors in…

FDA approves new treatment for HIV

FDA

The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older. The CDC estimates that 1.2 million persons ages 13 years and older are living…

Every Dose, Every Day (TM): New Tool to Improve Medication Adherence

Every Dose Every Day image

Editor’s Note: The Centers for Disease Control has developed a new digital toolkit to promote medical adherence. This online resource includes a mobile app and can be used by providers as well as people living with HIV. CDC recently published the Every Dose, Every DayTM toolkit online. This toolkit offers assistance to both health care…

CDC Supports New WHO Early Release HIV Treatment and PrEP Guidelines

CDC Logo

For Immediate Release: Wednesday, September 30, 2015 Contact: Media Relations, Office of Communication (404) 639-3286 CDC welcomes today’s announcement by the World Health Organization (WHO) of new Early Release HIV Treatment and Pre-Exposure Prophylaxis (PrEP) guidelines that will significantly increase the number of people eligible for life-saving anti-retroviral treatment (ART) and expand access to a powerful…

Articles Highlight Ryan White HIV/AIDS Program Role Providing HIV Care and Treatment Services

ryan white 25 years rectangle

As the Ryan White HIV/AIDS Program (RWHAP) commemorates its 25th this summer, two new articles published this week highlight the critical role the Program has in providing care and treatment services to low income people living with HIV in the United States. According to a new article in the Journal of the American Medical Association,…